• TG Therapeutics average return on equity for 2023 was -137.15, a 5.21% decline from 2022.
• TG Therapeutics average return on equity for 2022 was -144.69, a 56.24% decline from 2021.
• TG Therapeutics average return on equity for 2021 was -92.61, a 90.2% increase from 2020.

Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.